Company / Working Capital per Share
FATE THERAPEUTICS INC Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.52
FY2025
5-year range
$1.52 / $6.29
FY2021-FY2025
Trend
-41.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 4 consecutive years, from $6.29 in FY2021 to $1.52 in FY2025.
Based on SEC 10-K filings.
1.52 in FY2025 with a 5-year CAGR of -22.4%.
Declined from $3.01 to $1.52 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -28.0%
- 5-Year CAGR
- -22.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- FATE THERAPEUTICS INC's working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 41.0% year-over-year.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.52 | -41.0% |
| FY2024 | $2.57 | -14.5% |
| FY2023 | $3.01 | -25.8% |
| FY2022 | $4.05 | -35.6% |
| FY2021 | $6.29 | +16.6% |
| FY2020 | $5.40 | +75.2% |
| FY2019 | $3.08 | -8.9% |
| FY2018 | $3.38 | +52.8% |
| FY2017 | $2.21 | -18.7% |
| FY2016 | $2.72 | +7.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026